Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones

Neuroreport. 1996 Mar 22;7(4):921-3. doi: 10.1097/00001756-199603220-00018.


Glutathione levels are decreased in the substantia nigra of patients with Parkinson's disease. We studied whether glutathione depletion contributes to dopaminergic cell death using a specific inhibitor of glutathione biosynthesis, L-buthionine sulfoximine (BSO). We found no significant reduction of tyrosine hydroxylase-positive cells in the substantia nigra pars compacta (SNpc) when BSO was administered systemically to preweanling mice or locally to the SNpc of adult rats. However, the combination of BSO with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in preweanling mice and the combination of nigral injections of BSO with intrastriatal injections of MPP+ (1-methyl-4-phenylpyridinium), the active metabolite of MPTP in adult rats, potentiated the toxic effects of MPTP and MPP+ on nigral neurones. Our data show that glutathione depletion can result in cell death if the nigrostriatal system is metabolically compromised.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / toxicity*
  • Animals
  • Buthionine Sulfoximine / pharmacology
  • Dopamine Agents / toxicity*
  • Glutathione / metabolism*
  • MPTP Poisoning*
  • Mice
  • Mice, Inbred C57BL
  • Nerve Degeneration / physiology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Substantia Nigra / cytology
  • Substantia Nigra / drug effects*
  • Substantia Nigra / metabolism


  • Dopamine Agents
  • Buthionine Sulfoximine
  • Glutathione
  • 1-Methyl-4-phenylpyridinium